Trial Profile
A phase II Study of Carboplatin plus oral S1 in Chemo-Naive Patients with Squamous Cell Lung Cancer (OSAKA-LCSG1102)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2018
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 17 Dec 2018 Status changed from recruiting to completed.
- 17 May 2016 New trial record